Plasma levels of neurogenic inflammation related neuropeptides in pediatric patients with community-acquired pneumonia and their potential diagnostic value in distinguishing viral and bacterial pneumonia
Open Access
- 6 January 2024
- journal article
- research article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 183 (4) , 1619-1627
Abstract
Neurogenic inflammation is involved in the development and progression of respiratory inflammatory diseases. However, its role in community-acquired pneumonia (CAP) remains unclear. We therefore aimed to investigate plasma levels of neurogenic inflammation-related neuropeptides, calcitonin gene-related peptide (CGRP), substance P (SP), vasoactive intestinal peptide (VIP) and neuropeptide Y (NPY), and procalcitonin (PCT) in pediatric patients with CAP and to assess their diagnostic value in viral and bacterial/mixed pneumonia. A total of 124 pediatric patients with CAP (1 month-18 years old) and 56 healthy children of similar ages were prospectively enrolled. The patients were classified as viral (n = 99) and bacterial/mixed (n = 25) pneumonia. Plasma levels of the peptides were quantified by ELISA. ROC analysis was performed to evaluate possible diagnostic value of the peptides. While plasma levels of CGRP, VIP and PCT were significantly higher in patients with CAP than in the control group, respectively, NPY levels were significantly lower. Moreover, plasma levels of all neuropeptides and PCT were significantly higher in bacterial pneumonia patients compared to viral pneumonia patients. ROC analysis revealed that CGRP, SP and NPY had a diagnostic value in distinguishing viral and bacterial/mixed pneumonia.Conclusions: Our findings suggest that these neuropeptides may be implicated in pediatric CAP. CGRP, SP and NPY together may be a promising candidate in distinguishing viral and bacterial/mixed pneumonia, however, for this, further studies are needed. What is Known:• Neurogenic inflammation contributes to the development and progression of respiratory inflammatory diseases such as chronic obstructive pulmonary disease and bronchial asthma. What is New:• Plasma levels of neurogenic inflammation related neuropeptides calcitonin gene-related peptide, substance P, vasoactive intestinal peptide and neuropeptide Y are changed in pediatric community-acquired pneumonia. Calcitonin gene-related peptide, substance P and neuropeptide Y are promising candidates in distinguishing viral and bacterial/mixed pneumonia.Keywords
Funding Information
- Bolu Abant Izzet Baysal University (2022.08.23.1564)
- Abant Izzet Baysal University
This publication has 31 references indexed in Scilit:
- Bacteria activate sensory neurons that modulate pain and inflammationNature, 2013
- Procalcitonin as a biomarker of infectious diseasesThe Korean Journal of Internal Medicine, 2013
- Neuroimmunomodulative properties of dipeptidyl peptidase IV/CD26 in a TNBS‐induced model of colitis in miceJournal of Cellular Biochemistry, 2011
- Lower Plasma Neuropeptide Y Level in Patients With Atypical Febrile ConvulsionsThe Kaohsiung Journal of Medical Sciences, 2010
- Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP – Results from the German competence network CAPNETZRespiratory Research, 2009
- Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial StewardshipClinical Infectious Diseases, 2007
- Neurogenic mechanisms in bronchial inflammatory diseasesAllergy, 2004
- The role of substance P in inflammatory diseaseJournal of Cellular Physiology, 2004
- Toxic Rhinitis-Induced Changes of Human Nasal Mucosa InnervationToxicologic Pathology, 2003
- Vasoactive Intestinal Polypeptide as Mediator of AsthmaPulmonary Pharmacology & Therapeutics, 2001